Perry A. Genova, PhD - President & CEO

Dr. Genova is an accomplished biomedical professional with expertise in medical and pharmaceutical product innovation and development. Previously, he served as Global Vice President and Dose Form Leader for Metered Dose Inhalers with GlaxoSmithKline in Evreux, France. From 1996 through 2006 Dr. Genova was Vice President of Biomedical Engineering at Kos Pharmaceuticals where he built an integral part of Kos' lung delivery franchise while serving as the Project Team Leader for Kos' Inhaled Insulin program. Dr. Genova has authored over 30 scientific papers and presentations and has received 20 US patents to date. He has also been principally involved in a number of successful startup ventures including Quill Medical (acquired by Angiotech in 2006) and IEP Pharmaceutical Devices (acquired by Kos Pharmaceuticals in 1999).

John Autrey, MBA - Chief Financial Officer

Mr. Autrey is a hands-on financial executive with twenty-five years' experience as a CFO and controller in small technology development and manufacturing companies as well as high growth distribution and service organizations. John has served as full-time and part-time CFO in a variety of industries including a NASDAQ-traded telecommunications company, Pliant Systems, Inc, a medical device company, Quill Medical, an early stage drug delivery venture, and an office equipment distributor, IKON - Raleigh. Mr. Autrey is a member of the American Institute of Certified Public Accountants and the North Carolina Assocations of CPA's. He received a B.S. from the University of North Carolina at Chapel Hill and an M.B.A. from Wake Forest University.

Gary Pace, PhD, Esq. - Corporate Counsel

Dr. Pace has held executive management positions in several companies, including Novartis Corporation where he was a General Counsel, Gentris Corporation, a pharmacogenetic testing company, and Quill Medical, Inc., a medical device company where he led the legal negotiation for their structured buyout in 2006. Dr. Pace was recently an Assistant General Counsel for BASF Corporation responsible for patent matters for two of the Corporations' business units.